Kiran Patel

Kiran Patel

Auto-generated profile, based on publicly available information

Kiran Patel

University Hospitals of Coventry and Warwickshire, Coventry, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in The Lancet
Verified
Journal Article
Closed access
BSBadara Samb
Badara Samb
NDNina Desai
Nina Desai
SNSania Nishtar
Sania Nishtar
SMShanti Mendis
Shanti Mendis
HBHenk Bekedam
Henk Bekedam
CECarissa Etienne
Carissa Etienne

9 August 2018 in New England Journal of Medicine
Verified
Journal Article
Open access
AMAneil Malhotra
Aneil Malhotra
HDHarshil Dhutia
Harshil Dhutia
GFGherardo Finocchiaro
Gherardo Finocchiaro
SGSabiha Gati
Sabiha Gati
IBIan Beasley
Ian Beasley
SSSanjay Sharma
Sanjay Sharma
Reports on the incidence and causes of sudden cardiac death among young athletes have relied largely on estimated rates of participation and varied methods of reporting. We sought to investigate the incidence and causes of sudden cardiac death among adolescent soccer players in the United Kingdom.

1 July 2009 in JACC
Verified
Journal Article
Closed access
TPThanh T. Phan
Thanh T. Phan
KAKhalid Abozguia
Khalid Abozguia
GSGanesh Nallur Shivu
Ganesh Nallur Shivu
GMGnanadevan Mahadevan
Gnanadevan Mahadevan
IAIbrar Ahmed
Ibrar Ahmed
MFMichael Frenneaux
Michael Frenneaux

1 October 2012 in JACC
Verified
Journal Article
Closed access
FLFrancisco Leyva
Francisco Leyva
RTRobin J. Taylor
Robin J. Taylor
PFPaul W.X. Foley
Paul W.X. Foley
FUFraz Umar
Fraz Umar
LMLawrence J. Mulligan
Lawrence J. Mulligan
SPSanjay K. Prasad
Sanjay K. Prasad

3 October 2007 in EP Europace
Verified
Journal Article
Open access
PDF file
SCShajil Chalil
Shajil Chalil
PFPaul W.X. Foley
Paul W.X. Foley
SMSarkaw A. Muyhaldeen
Sarkaw A. Muyhaldeen
KPKiran C.R. Patel
Kiran C.R. Patel
ZYZaheer R. Yousef
Zaheer R. Yousef
FLFrancisco Leyva
Francisco Leyva
To determine whether myocardial scarring, quantified using late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR), predicts response to cardiac resynchronization therapy (CRT). A total of 45 patients with ischaemic cardiomyopathy [age 67.1 ± 10.4 years (mean ± SD)] underwent assessment of 6 min walking distance (6MWD) and quality of life (QoL) before and after CRT. Scar size (percentage of left ventricular mass), location, and transmurality were assessed prior to CRT using LGE-CMR. Responders (survived for 1year with no heart failure hospitalizations, and improvement by ≥1 NYHA classes or ≥25% 6MWD) had a higher left ventricular ejection fraction (P = 0.048), smaller scars (<33%) (P = 0.009), and fewer scars with ≥51% transmurality (P = 0.002). Scar size correlated negatively with change in 6MWD (r = −0.54, P < 0.001) and positively with changes in QoL scores (r = 0.35, P = 0.028). Responder rates in patients with <33% scar were higher than in those with ≥33% scar (82 vs. 35%, P < 0.01). Responder rates in patients with scar transmurality <51% were higher than in those with ≥51% (89 vs. 46%, P < 0.01). Among the patients with posterolateral scars, a transmurality value of ≥51% was associated with a particularly poor response rate (23%), compared with scars with <51% transmurality (88%, P < 0.001). In multivariate analyses, both scar size (P = 0.022) and transmurality (P = 0.004) emerged as predictors of response. In patients with posterolateral scars, pacing outside the scar was associated with a better responder rate than pacing over the scar (86 vs. 33%, P = 0.004). In patients with ischaemic cardiomyopathy, a scar size ≥33%, a transmurality ≥51%, and pacing over a posterolateral scar are associated with a suboptimal response to CRT.

11 August 2009 in Rheumatology
Verified
Journal Article
Open access
PDF file
APAthiveeraramapandian Prabu
Athiveeraramapandian Prabu
KPKiran Patel
Kiran Patel
CYChee-Seng Yee
Chee-Seng Yee
PNPeter Nightingale
Peter Nightingale
RSRohan D. Situnayake
Rohan D. Situnayake
CGCaroline Gordon
Caroline Gordon
Objectives. Pulmonary arterial hypertension (PAH) is associated with rapid deterioration and poor prognosis in SLE, especially during pregnancy. The prevalence of PAH in SLE in non-tertiary centres is uncertain. This study aims to estimate the point prevalence of PAH and identify risk factors for PAH in a large cohort of SLE patients. Methods. A prospective cross-sectional study of 288 patients with SLE were recruited from lupus clinics in Birmingham, UK. Resting transthoracic echocardiography was performed to estimate the pulmonary artery pressures and to assess cardiac morphology and function. PAH was defined as systolic pulmonary artery pressure (sPAP) >30 mmHg. We assessed potential risk factors such as the presence of lung disease, respiratory muscle weakness, autoantibodies, smoking, RP and APS. Results. Of 288 patients who consented for participation, 283 patients were suitable for analysis. Twelve patients were found to have PAH with sPAP >30 mmHg. The range of sPAP in our PAH patients was 31–59 mmHg and three patients had sPAP >40 mmHg. The only significant risk factor for PAH was LAC (P = 0.005). Conclusions. The point prevalence of PAH was 4.2% in our cohort of patients with SLE. Most of the PAH cases were found to be of mild severity (<40 mmHg). The significant association of LAC and presence of APS in PAH cases suggests that thrombosis may play an important role in PAH with SLE. This is important, as it is treatable.